Harbor

AI-native CRO for clinical trial operations

Y CombinatorSpring 2026ActiveHealthcare

What they do

Problem

Clinical trial operations are expensive and inefficient due to manual, fragmented service workflows for managing data and trial execution.

Solution

Harbor provides an AI-native CRO combining an AI-native electronic data capture system with full-service clinical trial execution and operations automation.

Who it's for

Drug and medical device companies that outsource clinical trial operations.

Founders

Albert Cai

Founder

Albert is the co-founder and CEO of Harbor. Before Harbor, Albert helped run clinical trials and regulatory strategy at Biolinq, helping take the company's first and flagship product from prototype through its first human studies and eventual FDA De Novo authorization. Albert studied biomedical engineering at the University of Michigan and attended boarding school at the Oklahoma School of Science and Mathematics.

Nathan H. Leung

Founder

Nate (CTO) is an ex-Google, ex-Ramp engineer who has built websites serving hundreds of thousands of visits per month and open-source projects with millions of downloads. He studied pure math at UCLA and computer science at the University of Michigan.

LinkedIn · X